Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic progressive external ophthalmoplegia.

Andrew G Lee1, Paul W Brazis

  • 1Department of Ophthalmology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, PFP, Iowa City, IA 52242, USA. andrew-lee@uiowa.edu

Current Neurology and Neuroscience Reports
|August 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apraxia of lid opening in multiple sclerosis.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2022
Same author

Sphenoid Sinusitis-Associated Optic Neuropathy: A Forgotten Disease.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2022
Same author

Posterior Ischemic Optic Neuropathy Following Recurrent COVID-19 in Prior Bilateral Sequential Nonarteritic Anterior Ischemic Optic Neuropathy.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2022
Same author

Optic nerve sheath diameter and spaceflight: defining shortcomings and future directions.

NPJ microgravity·2022
Same author

Progressive Optic Neuropathy in Cerebellar Ataxia, Areflexia, Optic Atrophy, and Sensorineural Hearing Loss Syndrome: The Importance of Targeted Gene Testing.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2022
Same author

Visual Loss as the Presenting Manifestation of Leptomeningeal Spread of Glioblastoma Multiforme to the Optic Chiasm.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2022

Chronic progressive external ophthalmoplegia (CPEO) involves progressive eye muscle weakness and drooping eyelids. Mitochondrial DNA mutations are a key cause, with new treatments under investigation.

Area of Science:

  • Ophthalmology
  • Neurology
  • Genetics

Background:

  • Chronic progressive external ophthalmoplegia (CPEO) is a clinical descriptor for heterogeneous disorders.
  • Key features include chronic, progressive, bilateral, and symmetric ocular motility deficits and ptosis.
  • Absence of pain, proptosis, or pupil involvement helps differentiate CPEO from other conditions.

Purpose of the Study:

  • To highlight the increasing recognition of mitochondrial DNA mutations as a cause of CPEO syndromes.
  • To emphasize the importance of recognizing specific CPEO syndromes with associated systemic and neurological findings.
  • To provide an overview of current treatment limitations and emerging therapeutic strategies.

Main Methods:

  • Review of clinical characteristics and diagnostic criteria for CPEO.

Related Experiment Videos

  • Analysis of the etiological role of mitochondrial DNA mutations in CPEO.
  • Synthesis of information on associated systemic, neurological, and other findings in CPEO syndromes.
  • Assessment of current therapeutic options and ongoing research into novel treatments.

    • Main Results:

    • Mitochondrial DNA mutations are a significant and increasingly identified etiology for CPEO.
    • CPEO syndromes present with variable systemic, neurological, and other clinical manifestations.
    • Current treatment options for CPEO are limited, necessitating further research.

    Conclusions:

    • CPEO encompasses a spectrum of disorders primarily linked to mitochondrial dysfunction.
    • Accurate diagnosis and recognition of associated syndromes are crucial for patient management.
    • Advancements in understanding mitochondrial genetics are paving the way for future therapeutic interventions.